메뉴 건너뛰기




Volumn 5, Issue , 2007, Pages

Clopidogrel in Orthopaedic patients: A review of current practice in Scotland

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; FONDAPARINUX; LOW MOLECULAR WEIGHT HEPARIN;

EID: 34347353062     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-5-6     Document Type: Review
Times cited : (26)

References (18)
  • 1
    • 34347359384 scopus 로고    scopus 로고
    • Indications for use and mechanism of action of clopidogrel
    • [Online]. [cited 2006 August 16]
    • Indications for use and mechanism of action of clopidogrel http://www.plavix.com [Online]. [cited 2006 August 16].
  • 2
    • 24944581693 scopus 로고    scopus 로고
    • Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: Comparing contributions from primary prevention and secondary prevention
    • 1215556 16107431 10.1136/bmj.38561.633345.8F
    • Unal B Critchley JA Capewell S Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: Comparing contributions from primary prevention and secondary prevention BMJ 2005 331 614 1215556 16107431 10.1136/bmj.38561.633345.8F
    • (2005) BMJ , vol.331 , pp. 614
    • Unal, B.1    Critchley, J.A.2    Capewell, S.3
  • 3
    • 31344481878 scopus 로고    scopus 로고
    • Secondary prevention of coronary heart disease in older patients after the national service framework: Population based study
    • 1336762 16401630 10.1136/bmj.38704.770127.BE
    • Ramsay SE Whincup PH Lawlor DA Secondary prevention of coronary heart disease in older patients after the national service framework: population based study BMJ 2006 332 144-5 1336762 16401630 10.1136/ bmj.38704.770127.BE
    • (2006) BMJ , vol.332 , pp. 144-145
    • Ramsay, S.E.1    Whincup, P.H.2    Lawlor, D.A.3
  • 5
    • 70450229172 scopus 로고    scopus 로고
    • British National Formulary (51) Section 2.9
    • British National Formulary (51) Section 2.9; 127
  • 6
    • 0037125390 scopus 로고    scopus 로고
    • The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting
    • 10.1016/S0735-1097(02)01954-X 12106925
    • Hongo RH Ley J Dick SE The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting J Am Coll Cardiol 2002 40 2 231-7 10.1016/S0735-1097(02)01954-X 12106925
    • (2002) J Am Coll Cardiol , vol.40 , Issue.2 , pp. 231-237
    • Hongo, R.H.1    Ley, J.2    Dick, S.E.3
  • 7
    • 0035671531 scopus 로고    scopus 로고
    • Effect of clopidogrel on bleeding after coronary artery bypass surgery
    • 10.1097/00003246-200112000-00006 11801823
    • Yende S Wunderink RG Effect of clopidogrel on bleeding after coronary artery bypass surgery Crit Care Med 2001 29 12 2271-5 10.1097/ 00003246-200112000-00006 11801823
    • (2001) Crit Care Med , vol.29 , Issue.12 , pp. 2271-2275
    • Yende, S.1    Wunderink, R.G.2
  • 8
    • 0000059457 scopus 로고    scopus 로고
    • Risk of post-operative hemorrhage associated with ticlopidine or clopidogrel use prior to coronary artery bypass grafting
    • Abstract 3145
    • Swarup V Oh CJ Richard EN Risk of post-operative hemorrhage associated with ticlopidine or clopidogrel use prior to coronary artery bypass grafting Circulation 2000 102 8 Suppl 2 Abstract 3145.
    • (2000) Circulation , vol.102 , Issue.8 SUPPL. 2
    • Swarup, V.1    Oh, C.J.2    Richard, E.N.3
  • 9
    • 4444229924 scopus 로고    scopus 로고
    • Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial
    • 10.1161/01.CIR.0000140675.85342.1B 15313956
    • Fox KA Mehta SR Peters R Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 2004 110 10 1202-8 10.1161/ 01.CIR.0000140675.85342.1B 15313956
    • (2004) Circulation , vol.110 , Issue.10 , pp. 1202-1208
    • Fox, K.A.1    Mehta, S.R.2    Peters, R.3
  • 10
    • 0037812402 scopus 로고    scopus 로고
    • Postoperative deep vein thrombosis prophylaxis: A retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting
    • 12735619
    • Ennis RS Postoperative deep vein thrombosis prophylaxis: A retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting J South Orthop Assoc 2003 12 1 10-7 12735619
    • (2003) J South Orthop Assoc , vol.12 , Issue.1 , pp. 10-17
    • Ennis, R.S.1
  • 11
    • 0034024268 scopus 로고    scopus 로고
    • Prophylaxis against deep vein thrombosis following total hip replacement: Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery
    • 10.1302/0301-620X.82B4.10452 10855864
    • Gillespie W Murray D Gregg PJ Prophylaxis against deep vein thrombosis following total hip replacement: Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery J Bone Joint Surg Br 2000 82 475-9 10.1302/0301-620X.82B4.10452 10855864
    • (2000) J Bone Joint Surg Br , vol.82 , pp. 475-479
    • Gillespie, W.1    Murray, D.2    Gregg, P.J.3
  • 12
    • 34347358307 scopus 로고    scopus 로고
    • Heparin, Low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures
    • Cochrane Review Heparin, Low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures Cochrane Library 2001
    • (2001) Cochrane Library
  • 13
    • 0034655567 scopus 로고    scopus 로고
    • Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
    • 10.1016/S0140-6736(00)02110-3 10776741
    • Collaborative group Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial Lancet 2000 355 1295-1302 10.1016/S0140-6736(00)02110-3 10776741
    • (2000) Lancet , vol.355 , pp. 1295-1302
  • 14
    • 0028899055 scopus 로고
    • Differences in mortality after fracture of hip: The east Anglian audit
    • 7719180
    • Todd CJ Freeman CJ Camilleri-Ferrante C Differences in mortality after fracture of hip: The east Anglian audit BMJ 1995 310 904-8 7719180
    • (1995) BMJ , vol.310 , pp. 904-908
    • Todd, C.J.1    Freeman, C.J.2    Camilleri-Ferrante, C.3
  • 15
    • 34250320216 scopus 로고    scopus 로고
    • Venous Thromboembolism: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing surgery
    • NICE 46
    • National Institute for Clinical Excellence guideline NICE 46 Venous Thromboembolism: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients undergoing surgery 2007
    • (2007)
  • 17
    • 0022974958 scopus 로고
    • Hip fractures in healthy patients: Operative delay versus prognosis
    • 1341980 3096430
    • Villar RN Allen SM Barnes SJ Hip fractures in healthy patients: operative delay versus prognosis Br Med J (Clin Res Ed) 1986 293 1203-4 1341980 3096430
    • (1986) Br Med J (Clin Res Ed) , vol.293 , pp. 1203-1204
    • Villar, R.N.1    Allen, S.M.2    Barnes, S.J.3
  • 18
    • 0029926296 scopus 로고    scopus 로고
    • Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip
    • 8609137
    • Hefley FG Jr Nelson CL Puskarich-May CL Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip J Bone Joint Surg Am 1996 78 581-3 8609137
    • (1996) J Bone Joint Surg Am , vol.78 , pp. 581-583
    • Hefley Jr., F.G.1    Nelson, C.L.2    Puskarich-May, C.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.